US2014221656A1PendingUtilityA1
Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
Est. expiryJul 8, 2031(~5 yrs left)· nominal 20-yr term from priority
Inventors:Norbert NagelBruno BaumgartnerHarald BerchtoldOliver PlettenburgDieter KadereitMandy MohnickeSimon GesslerJoachim Tillner
A61P 37/02A61P 9/08A61P 9/12A61P 3/10A61P 9/00A61P 9/10A61P 43/00A61P 5/00A61P 25/28A61P 25/04A61P 27/02A61P 35/00A61P 3/00A61P 29/00A61P 27/06A61P 31/04A61P 13/12A61P 13/08A61P 15/10A61P 19/08A61P 15/00A61P 1/16A61P 15/06A61P 11/00A61P 11/06C07D 401/12A61K 31/4725
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to crystalline solvates of 6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride, processes for their preparation and the use thereof.
Claims
exact text as granted — not AI-modified1 . A crystalline hydrate of 6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride having the formula
2 .- 22 . (canceled)
23 . A process for preparing a crystalline hydrate of 6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride having the formula
comprising the steps of:
(a) dissolving 6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride in a suitable solvent containing water or in water alone at a temperature suitable to obtain a solution,
(b) concentrating the solution by evaporating the solvent partially sufficient to allow formation of hydrate crystals or cooling down the solution and maintaining it for a time period sufficient to allow formation of hydrate crystals and
(c) isolating the hydrate.
24 . The process according to claim 23 wherein the crystalline hydrate contains 1.85 to 2.2 molecules water per molecule (I).
25 . The process according to claim 23 wherein the crystalline hydrate contains 2.0 molecules water per molecule (I).
26 . The process according to claim 23 , wherein the crystalline hydrate contains 10.5-12.5% (w/w) water.
27 . The process according to claim 23 wherein the suitable solvent containing water for dissolving and crystallizing 6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one is selected from the group consisting of acetone, methyl ethyl ketone, methanol, ethanol, isopropanol, tetrahydrofuran and acetonitrile.
28 . The process according to claim 23 wherein the suitable solvent is water.
29 . The process according to claim 27 wherein said suitable solvent containing water is acetone.
30 . The process according to claim 1 wherein the suitable solvent containing water is in a ratio of about 1-4 parts solvent to about 1-4 parts water by volume.
31 . The process according to claim 30 wherein the suitable solvent containing water is in a ratio of 4 parts solvent to 1 part water by volume.
32 . The process according to claim 29 wherein the acetone/water ratio is 3:1 by volume.
33 . The process according to claim 29 wherein the acetone/water ratio is 3:2 by volume.
34 . The process according to claim 23 wherein the temperature suitable to obtain a solution is about 55° C. to about 70° C.
35 . The process according to claim 34 wherein the temperature suitable to obtain a solution is about 65° C.
36 . The process according to claim 23 wherein step b further comprises the step of seeding the solution with dihydrate crystals.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.